A Safety and Efficacy Study of Duvelisib in Relapsed/Refractory Follicular Lymphoma
Clinical trial NCT04707079 · UNKNOWN
Trial details
- NCT number
- NCT04707079
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-18
- Primary completion
- 2021-10-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.